EIGR
Eiger BioPharmaceuticals, Inc.
EIGR
EIGR
Delisted
EIGR was delisted on the 10th of April, 2024.
43 hedge funds and large institutions have $4.17M invested in Eiger BioPharmaceuticals, Inc. in 2023 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 7 increasing their positions, 15 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
43
Holding in Top 10
–
Calls
$1K
Puts
–
Top Buyers
| 1 | +$77K | |
| 2 | +$6K | |
| 3 | +$4.81K | |
| 4 |
Jane Street
New York
|
+$3.32K |
| 5 |
Prudential Financial
Newark,
New Jersey
|
+$2.69K |
Top Sellers
| 1 | -$824K | |
| 2 | -$244K | |
| 3 | -$123K | |
| 4 |
UOC
UBS O'Connor
Chicago,
Illinois
|
-$120K |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$109K |